Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
University of Pennsylvania
Filadelfia, Estados UnidosPublicacións en colaboración con investigadores/as de University of Pennsylvania (36)
2024
-
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4
Journal of Cardiac Failure
-
Evolution and advancements in genomics and epigenomics in OA research: How far we have come
Osteoarthritis and Cartilage
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
2023
-
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45
-
Structure-function-guided design of synthetic peptides with anti-infective activity derived from wasp venom
Cell Reports Physical Science, Vol. 4, Núm. 7
-
Three decades of advancements in osteoarthritis research: insights from transcriptomic, proteomic, and metabolomic studies
Osteoarthritis and Cartilage
2022
-
Antimicrobial Peptides: Potential Therapeutics Against Drug-Resistant Pulmonary Infections
Archivos de Bronconeumologia
-
Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond
International Journal of Molecular Sciences, Vol. 23, Núm. 23
2021
-
Author Correction: Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications (Scientific Reports, (2021), 11, 1, (1526), 10.1038/s41598-021-81093-y)
Scientific Reports
-
Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications
Scientific Reports, Vol. 11, Núm. 1
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus
Circulation: Genomic and Precision Medicine, Vol. 13, Núm. 6, pp. E002769
-
Light-Emitting Probes for Labeling Peptides
Cell Reports Physical Science, Vol. 1, Núm. 12
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 396, Núm. 10253, pp. 759-769
-
Micelle-directed chiral seeded growth on anisotropic gold nanocrystals
Science (New York, N.Y.), Vol. 368, Núm. 6498, pp. 1472-1477
2019
-
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors
Nature Genetics, Vol. 51, Núm. 5, pp. 804-814
2018
-
Erratum to: Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition (Nature Genetics, (2018), 50, 4, (572-580), 10.1038/s41588-018-0088-x)
Nature Genetics
-
Multicenter phase II study of lurbinectedin in BRCAMutated and unselected metastatic advanced breast cancer and biomarker assessment substudy
Journal of Clinical Oncology, Vol. 36, Núm. 31, pp. 3134-3143
-
Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition
Nature Genetics, Vol. 50, Núm. 4, pp. 572-580
-
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
The Lancet Neurology, Vol. 17, Núm. 12, pp. 1053-1060